SOUTH
SAN FRANCISCO, Calif., Aug. 30,
2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.
(Nasdaq: RIGL) today announced that Raul
Rodriguez, the company's president and chief executive
officer, and Dean Schorno, the
company's chief financial officer, will participate in the
following investor conferences in September:
- 2023 Wells Fargo Healthcare Conference, September 6-8, 2023, Boston, MA
Raul
Rodriguez will present a company overview on Wednesday, September 6th at
12:45 p.m. ET.
- Citi's 18th Annual BioPharma Conference, September 6-7, 2023, Boston, MA
Rigel management will
participate in one-on-one meetings on Thursday, September 7th.
To access the live webcast of the Wells Fargo Healthcare
Conference presentation, visit the Investor Relations section of
the company's website at www.rigel.com. Please connect to
Rigel's website prior to the start of the live webcast to allow for
any software downloads.
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq:
RIGL) is a biotechnology company dedicated to discovering,
developing and providing novel therapies that significantly improve
the lives of patients with hematologic disorders and cancer.
Founded in 1996, Rigel is based in South
San Francisco, California. For more information on Rigel,
the Company's marketed products and pipeline of potential products,
visit www.rigel.com.
Investors & Media Contacts:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com
Media:
David
Rosen
Argot Partners
Phone: 212.600.1902
Email: david.rosen@argotpartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/rigel-to-participate-in-upcoming-september-investor-conferences-301913181.html
SOURCE Rigel Pharmaceuticals, Inc.